Redeye: AVTECH Q2 2023 - Mispriced growth potential with short-term catalysts
Redeye states that AVTECH is well positioned to grow, which we do not believe is reflected in the valuation. Moreover, we view the downside as limited with the recently extended Southwest agreement. Thus, we re-evaluate our bear case.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/